CLARION PSYCHIATRIC HOSPITAL
1. Target Overview & Investment Thesis
CLARION PSYCHIATRIC HOSPITAL is a 112-bed suburban community hospital in CLARION, PA with $27.8M in net patient revenue and a 22.5% operating margin. The hospital serves a payer mix of 3.3% Medicare, 6.0% Medicaid, and 90.7% commercial.
Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 22.5% to 29.9% (+736bps).
| Net Revenue HCRIS | $27.8M |
| Current EBITDA COMPUTED | $6.3M |
| Operating Margin COMPUTED | 22.5% |
| Occupancy HCRIS | 70.5% |
| Revenue / Bed COMPUTED | $248K |
| Net-to-Gross HCRIS | 47.0% |
| Distress Probability ML | 46.2% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 22.5% places it above the state median. Among 101 size-comparable peers (56-224 beds), the median margin is -6.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (56-224), prioritizing same-state peers. 101 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CLARION PSYCHIATRIC HOSPITAL (Target) | PA | 112 | $27.8M | 22.5% |
| ST LUKE HOSPITAL ANDERSON CAMP | PA | 193 | $433.0M | 20.6% |
| THE GETTYSBURG HOSPITAL | PA | 76 | $341.8M | 18.4% |
| ST. JOSEPH MEDICAL CENTER | PA | 132 | $334.8M | 13.2% |
| EPHRATA COMMUNITY HOSPITAL | PA | 115 | $291.8M | 3.8% |
| EINSTEIN MEDICAL CENTER MONTGO | PA | 175 | $276.3M | 6.9% |
| THE GOOD SAMARITAN HOSPITAL | PA | 145 | $269.5M | -5.0% |
| WILKES-BARRE GENERAL HOSPITAL | PA | 188 | $262.1M | -13.0% |
| UPMC ST MARGARET | PA | 185 | $248.5M | -21.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $584K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $556K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $550K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $338K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $18K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $6.3M |
| + RCM Uplift | +$2.0M |
| Pro Forma EBITDA | $8.3M |
| Current Margin | 22.5% |
| Pro Forma Margin | 29.9% |
| WC Released (1x) | $1.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $9.6M | $61.7M | 6.41x | 45.0% |
| Base (11x exit) | 10.0x | 11.0x | $9.6M | $71.0M | 7.38x | 49.1% |
| Bull Case | 9.0x | 11.0x | $8.7M | $80.9M | 9.34x | 56.3% |
| Bull (12x exit) | 9.0x | 12.0x | $8.7M | $90.8M | 10.48x | 60.0% |
| Bear Case | 11.0x | 10.0x | $10.6M | $48.4M | 4.57x | 35.5% |
| Bear (11x exit) | 11.0x | 11.0x | $10.6M | $56.7M | 5.35x | 39.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 101 hospitals with 56-224 beds
- Same-state prioritization (n=102)
- Comp margins: P25=-19.1% / P50=-6.5% / P75=7.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.